Consequently, CRTd patients in the GLP-1 RA groups vs. controls have a significant reduction of hospital admissions for HF worsening (without affecting the mortality) and of AF/VT events, and an increase in CRTd responders rate. This evidence concerns the gene GCG and hydrops fetalis.